uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Prehospital diagnosis and start of treatment reduce time delay and mortality in real life patients with ST-elevation myocardial infarction
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences.
Show others and affiliations
Article in journal (Refereed) Submitted
URN: urn:nbn:se:uu:diva-93680OAI: oai:DiVA.org:uu-93680DiVA: diva2:167229
Available from: 2005-11-03 Created: 2005-11-03Bibliographically approved
In thesis
1. Early Risk Stratification, Treatment and Outcome in ST-elevation Myocardial Infarction
Open this publication in new window or tab >>Early Risk Stratification, Treatment and Outcome in ST-elevation Myocardial Infarction
2005 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

We evaluated, in patients with ST-elevation myocardial infarction (STEMI) treated with thrombolytics, admission Troponin T (tnT), ST-segment resolution and admission N-terminal pro-brain natriuretic peptide (NT-proBNP) for early risk stratification as well as time delays and outcome in real life patients according to prehospital or in-hospital thrombolytic treatment. Also, baseline characteristics, treatments and outcome in patients enrolled in the ASSENT-2 trial in Sweden and in patients not enrolled were evaluated.

TnT (n=881) and NT-proBNP (n=782) on admission and ST-resolution at 60 minutes (n=516) in patients from the ASSENT-2 and ASSENT-PLUS trials were analysed. Elevated levels of NT-proBNP and tnT on admission were both independently related to one-year mortality. However, when adding information on ST-resolution (</≥50%) 60 minutes after initiation of thrombolytic treatment, tnT no longer contributed independently to mortality prediction. High and low risk patients were best identified by a combination of NT-proBNP and ST-resolution at 60 minutes.

We investigated consecutive STEMI patients included in the RIKS-HIA registry between 2001 and 2004, if they were ambulance transported and had received prehospital (n=1690) or in-hospital (n=3685) thrombolytic treatment. Prehospital diagnosis and thrombolysis reduced the time to thrombolysis by almost one hour, were associated with better left ventricular function and fewer complications and reduced the adjusted one-year mortality by 30% compared with in-hospital thrombolysis.

Prospective data from the RIKS-HIA registry on STEMI patients treated with thrombolytics were linked to data on trial participants in the ASSENT-2 trial of thrombolytic agents and used for direct comparisons. Patients treated with thrombolytics and not enrolled in a clinical trial at trial hospitals (n=2048) had higher risk characteristics, more early complications and twice as high adjusted one-year mortality compared to those enrolled (n=729). One major reason for the difference in outcome appeared to be the selection of less critically ill patients to the trial.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2005. 70 p.
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 81
Medicine, Acute myocardial infarction, Thrombolysis, Troponin, Electrocardiography, Natriuretic peptide, Prognosis, Prehospital thrombolysis, Treatment delay, Mortality, Registry, Clinical trial, Medicin
National Category
Dermatology and Venereal Diseases
urn:nbn:se:uu:diva-6050 (URN)91-554-6384-3 (ISBN)
Public defence
2005-11-25, Robergsalen, Ingång 40, Akademiska sjukhuset, Uppsala, 13:15
Available from: 2005-11-03 Created: 2005-11-03 Last updated: 2013-06-20Bibliographically approved

Open Access in DiVA

No full text

By organisation
Department of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 136 hits
ReferencesLink to record
Permanent link

Direct link